Response of bone turnover markers to bisphosphonate treatment in Paget's disease.

被引：0
|
作者：
Gill, KA [1 ]
Naylor, KE [1 ]
Ellison, JV [1 ]
Bainbridge, PR [1 ]
Eastell, R [1 ]
机构：
[1] Univ Sheffield, Div Clin Sci, Bone Metab Grp, Sheffield S10 2TN, S Yorkshire, England
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P52
引用
收藏
页码：1050 / 1050
页数：1
相关论文
共 50 条
  • [11] Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid
    Polyzos, Stergios A.
    Anastasilakis, Athanasios D.
    Anagnostis, Panagiotis
    Kita, Marina
    Arsos, Georgios
    Moralidis, Efstratios
    Papatheodorous, Athanasios
    Terpos, Evangelos
    ENDOKRYNOLOGIA POLSKA, 2012, 63 (04) : 312 - 315
  • [12] Biochemical markers of bone turnover in the assessment of response to tiludronate in Paget's disease
    Alvarez, L
    Guañabens, N
    Peris, P
    Vidal, S
    Ros, I
    Monegal, A
    Bedini, JL
    Deulofeu, R
    Pons, F
    Muñoz-Gómez, J
    Ballesta, AM
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S61 - S61
  • [13] Biochemical markers of bone turnover in predicting response to clodronate therapy in Paget's disease
    Parker, CR
    Blackwell, PJ
    Lawson, N
    Hosking, DJ
    BONE, 1999, 24 (05) : 68S - 68S
  • [14] The effect of different bisphosphonate treatment in Paget's disease of bone
    Donáth, J
    Tóth, L
    Poór, G
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S112 - S112
  • [15] Current perspectives on bisphosphonate treatment in Paget's disease of bone
    Wat, Winnie Zee Man
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 977 - 983
  • [16] Bisphosphonate treatment of Paget's disease of bone with pamidronate.
    Grauer, A
    Klar, B
    Knaus, J
    Scharla, SH
    Ziegler, R
    MEDIZINISCHE KLINIK, 1996, 91 (01) : 14 - 19
  • [17] BIOCHEMICAL MARKERS OF BONE TURNOVER IN PAGET DISEASE
    ALVAREZ, L
    GUANABENS, N
    DEOSABA, MJM
    PERIS, P
    MONEGAL, A
    PALLARES, M
    MUNOZGOMEZ, J
    RIVERA, F
    BALLESTA, AM
    CALCIFIED TISSUE INTERNATIONAL, 1994, 54 (05) : 447 - 447
  • [18] Predictors of response to tiludronate in Paget's bone disease.
    MoralesPiga, A
    AbrairaSantos, V
    Prous, A
    ReyRey, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M761 - M761
  • [19] Prediction and assessment of the response of Paget's disease to bisphosphonate treatment
    Hosking, DK
    BONE, 1999, 24 (05) : 69S - 71S
  • [20] EFFECT OF ZOLEDRONIC ACID ON THE BONE TURNOVER MARKERS IN THE PAGET'S DISEASE
    Moro-Alvarez, M. J.
    Serrano, R.
    Espinoza, J.
    Andrade, M.
    de la Piedra, C.
    Diaz-Curiel, M.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 82 - 82
12345